Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab 80 mg Dose Escalation in RA
NCT01270035Phase 4Unknown
- Sponsor
- Keio University
- Start
- Jan 2011
- Primary completion
- Jan 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Keio University. Status: unknown.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01270035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270035.